Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 27/Signature 1

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/11

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 12: Figure S12

Description: Differentially abundant taxa between the VANM group and HR (H-Isoniazid, R-Rifampin) treatment group.

Abundance in Group 1: increased abundance in HR (H-Isoniazid, R-Rifampin)

NCBI	Quality Control	Links
Anaerosporobacter
Acetatifactor
Intestinimonas
Anaerostipes
Enterorhabdus
Erysipelotrichaceae
Anaeroplasma
Arthrobacter
Mucispirillum
Erysipelothrix
Roseburia
Pseudoflavonifractor
Eubacterium
unclassified Thomasclavelia
Dysgonomonas
Blautia
Alistipes
Oscillibacter
Akkermansia
Lachnospiraceae
Coprobacter
Bacteroides
Tannerella

Revision editor(s): KateRasheed